A mechanism for antibody-mediated outside-in activation of LFA-1

被引:5
作者
Carreno, Roberto [1 ]
Li, Dan [2 ]
Sen, Mehmet [1 ]
Nira, Iris [1 ]
Yamakawa, Tatsuo [1 ]
Ma, Qing [2 ]
Legge, Glen B. [1 ]
机构
[1] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.M704699200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MEM83 is an inserted domain (I-domain)-specific antibody that up-regulates the interaction of LFA-1 with ICAM-1 through an outside-in activation mechanism. We demonstrate here that there is no change in the affinity of the MEM83 antibody for the I-domain in either its low (wild-type) or high affinity form and that MEM83 does not enhance the binding of the wild-type I-domain to ICAM-1. Furthermore, we show that the antibody acts as an activating agent to induce LFA-1/ICAM-1-dependent homotypic cell aggregation only as an IgG, but not as a Fab fragment. On the basis of these data, we propose an avidity-based mechanism that requires no direct activation of the LFA-1 I-domain by the binding of the antibody; rather, activation is enhanced when there is an interaction with both arms of the IgG. A molecular model of the antibody interaction with LFA-1 illustrates the symmetry and accessibility of the two MEM83 epitopes across the LFA-1/ICAM-1 heterotetramer. We hypothesize that MEM83 stabilizes adjacent LFA-1 molecules in their active form by the free energy that is gained from the binding of the I-domains to each arm of the IgG. This leads to stabilization of the open state of the integrin and outside-in signaling. Our model supports a mechanism in which both affinity and avidity regulation are required in the activation of LFA-1.
引用
收藏
页码:10642 / 10648
页数:7
相关论文
共 70 条
[1]   Mechanisms of T cell tolerance and suppression in cancer mediated by tumor-associated antigens and hormones [J].
Adler, Adam J. .
CURRENT CANCER DRUG TARGETS, 2007, 7 (01) :3-14
[2]   Does the integrin αA domain act as a ligand for its βA domain? [J].
Alonso, JL ;
Essafi, M ;
Xiong, JP ;
Stehle, T ;
Arnaout, MA .
CURRENT BIOLOGY, 2002, 12 (10) :R340-R342
[3]   KIM185, A MONOCLONAL-ANTIBODY TO CD18 WHICH INDUCES A CHANGE IN THE CONFORMATION OF CD18 AND PROMOTES BOTH LFA-1-DEPENDENT AND CR3-DEPENDENT ADHESION [J].
ANDREW, D ;
SHOCK, A ;
BALL, E ;
ORTLEPP, S ;
BELL, J ;
ROBINSON, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2217-2222
[4]   Importance of force linkage in mechanochemistry of adhesion receptors [J].
Astrof, Nathan S. ;
Salas, Azucena ;
Shimaoka, Motomu ;
Chen, JianFeng ;
Springer, Timothy A. .
BIOCHEMISTRY, 2006, 45 (50) :15020-15028
[5]   THE LW BLOOD-GROUP GLYCOPROTEIN IS HOMOLOGOUS TO INTERCELLULAR-ADHESION MOLECULES [J].
BAILLY, P ;
HERMAND, P ;
CALLEBAUT, I ;
SONNEBORN, HH ;
KHAMLICHI, S ;
MORNON, JP ;
CARTRON, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5306-5310
[6]  
BAZIL V, 1990, FOLIA BIOL-PRAGUE, V36, P41
[7]   Antibodies that selectively inhibit leukocyte function-associated antigen 1 binding to intercellular adhesion molecule-3 recognize a unique epitope within the CD11a I domain [J].
Binnerts, ME ;
vanKooyk, Y ;
Edwards, CP ;
Champe, M ;
Presta, L ;
Bodary, SC ;
Figdor, CG ;
Berman, PW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) :9962-9968
[8]   DISTINCT BINDING OF T-LYMPHOCYTES TO ICAM-1, ICAM-2 OR ICAM-3 UPON ACTIVATION OF LFA-1 [J].
BINNERTS, ME ;
VANKOOYK, Y ;
SIMMONS, DL ;
FIGDOR, CG .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) :2155-2160
[9]   Lymphocyte homing and homeostasis [J].
Butcher, EC ;
Picker, LJ .
SCIENCE, 1996, 272 (5258) :60-66
[10]   LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation [J].
Carrasco, YR ;
Fleire, SJ ;
Cameron, T ;
Dustin, ML ;
Batista, FD .
IMMUNITY, 2004, 20 (05) :589-599